Toggle navigation
About
Abstract
Editorial Board
Publication Schedule
Subscription & Newsletter
Contact
Issue
9-2
Table of Contents
Editors Selection
Glaucoma Dialogue
Glaucoma Opinion
Abstracts
Abstracts
Abstracted Journals
Classification List
Index of Authors
Search
Home
Abstracts
Journals
Journal #67
advertisement
Canadian Journal of Ophthalmology
16
Showing records 1 to 16 |
Display all abstracts in
Canadian Journal of Ophthalmology
17985
Self-reported glaucoma in Canada: Findings from population-based surveys, 1994-2003
Perruccio AV; Badley EM; Trope GE
Canadian Journal of Ophthalmology
2007; 42: 219-226
17990
Measurement of anterior lens growth after acute primary angle-closure glaucoma
Yip LW; Aquino MC; Chew PT
Canadian Journal of Ophthalmology
2007; 42: 321-322
17963
Should we treat the brain in glaucoma?
Gupta N; YĆ¼cel YH
Canadian Journal of Ophthalmology
2007; 42: 409-413
17973
From ocular hypertension to ganglion cell death: a theoretical sequence of events leading to glaucoma
Nickells RW
Canadian Journal of Ophthalmology
2007; 42: 278-287
18010
Special considerations in low-tension glaucoma
Krupin T
Canadian Journal of Ophthalmology
2007; 42: 414-417
17983
Sleep-disordered breathing and effects on ocular health
Dhillon S; Shapiro CM; Flanagan J
Canadian Journal of Ophthalmology
2007; 42: 238-243
18078
Is this neuroprotective drug good for my glaucoma patients? Some key factors in clinical decision-making
Goldberg I
Canadian Journal of Ophthalmology
2007; 42: 418-420
18034
Axonal loss and neuroprotection in optic neuropathies
Levin LA
Canadian Journal of Ophthalmology
2007; 42: 403-408
18077
Assessment of the optic disc to measure neuroprotection
Mikelberg FS
Canadian Journal of Ophthalmology
2007; 42: 421-424
18076
Natural compounds: Evidence for a protective role in eye disease
Ritch R
Canadian Journal of Ophthalmology
2007; 42: 425-438
18075
Modulating the immune system: a vaccine for glaucoma?
Schwartz M
Canadian Journal of Ophthalmology
2007; 42: 439-441
17975
Glaucoma neuroprotection: What is it? Why is it needed?
Weinreb RN
Canadian Journal of Ophthalmology
2007; 42: 396-398
18073
Ocular drug delivery: molecules, cells, and genes
Liu X; Brandt CR; Rasmussen CA; Kaufman PL
Canadian Journal of Ophthalmology
2007; 42: 447-454
17986
Comparison of silicone and polypropylene Ahmed glaucoma valves: Two-year follow-up
Mackenzie PJ; Schertzer RM; Isbister CM
Canadian Journal of Ophthalmology
2007; 42: 227-232
17981
Laser treatment to large iris cyst secondary to trabeculectomy
Duan X; Zhang Y; Wang N
Canadian Journal of Ophthalmology
2007; 42: 316-317
18062
Community-acquired bleb-related endophthalmitis caused by vancomycin-resistant enterococci
Tang CW; Cheng CK; Lee TS
Canadian Journal of Ophthalmology
2007; 42: 477-478
Issue
9-2
Table of Contents
Editor's Selection
Change Issue
24-1 (2024)
23-4 (2023)
23-3 (2023)
23-2 (2023)
23-1 (2022)
22-4 (2022)
22-3 (2022)
22-2 (2021)
22-1 (2021)
21-4 (2021)
21-3 (2021)
21-2 (2021)
21-1 (2020)
20-4 (2020)
20-3 (2020)
20-2 (2019)
20-1 (2019)
19-4 (2019)
19-3 (2018)
19-2 (2018)
19-1 (2018)
18-4 (2017)
18-3 (2017)
18-2 (2017)
18-1 (2017)
17-4 (2016)
17-3 (2016)
17-2 (2016)
17-1 (2016)
16-4 (2015)
16-3 (2015)
16-2 (2015)
16-1 (2014)
15-4 (2014)
15-3 (2014)
15-2 (2013)
15-1 (2013)
14-4 (2013)
14-3 (2013)
14-2 (2013)
14-1 (2012)
13-4 (2012)
13-3 (2011)
13-2 (2011)
13-1 (2011)
12-4 (2011)
12-3 (2010)
12-2 (2010)
12-1 (2010)
11-4 (2010)
11-3 (2009)
11-2 (2009)
11-1 (2009)
10-4 (2009)
10-3 (2008)
10-2 (2008)
10-1 (2008)
9-4 (2008)
9-3 (2007)
9-2 (2007)
9-1 (2007)
8-4 (2007)
8-3 (2006)
8-2 (2006)
8-1 (2006)
7-3 (2006)
7-2 (2005)
7-1 (2005)
6-3 (2005)
6-2 (2004)
6-1 (2004)
5-3 (2004)
5-2 (2003)
5-1 (2003)
4-3 (2003)
4-2 (2002)
4-1 (2002)
3-3 (2002)
3-2 (2001)
3-1 (2001)
2-3 (2001)
2-2 (2000)
2-1 (2000)
1-3 (2000)
1-2 (1999)
1-1 (1999)
advertisement